The use of PSMA PET scans should not be limited to patients who have met the Phoenix criteria of BCR after RT, since PSMA PET scans can be used to localize recurrent PCa at low PSA levels, and local salvage therapy can be initiated at PSA levels below the Phoenix criteria [44]. The gene discussed is FOLH1; the disease is posterior cortical atrophy.